Study guide

10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

COPR Primary Care Paramedic PCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The COPR PCP Exam & How to Use This Guide

0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan

2 Chapter 1: Professionalism, Ethics & Legal Framework

1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent

3 Chapter 2: Patient-Centred Communication & Clinical Documentation

2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans

4 Chapter 3: Interprofessional Collaboration & Continuum of Care

3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans

5 Chapter 4: Evidence-Informed Practice & Continuing Competence

4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession

6 Chapter 5: Professional Health, Safety & Operational Resilience

5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice

7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care

6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation

8 Chapter 7: Situational Leadership & Scene Operations

7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems

9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness

8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources

10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs

9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment

11 Chapter 10: Diagnostic Monitoring: ECG & Capnography

10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

12 Chapter 11: Airway Management & Ventilation Therapeutics

11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy

13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care

12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine

14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR

13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation

15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies

14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies

16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation

15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting

17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients

16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities

18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology

17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States

19 Chapter 18: Pharmacology & Safe Medication Administration

18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration

20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement

19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care

21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use

20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

Key Takeaways Explain This Topic AI

Continuous infrared waveform capnography provides real-time quantitative partial pressure of end-tidal carbon dioxide (EtCO2) and ventilation dynamics, far exceeding qualitative colorimetric chemical devices which only reflect broad pH changes and are prone to false negatives in low-flow states.

A normal capnogram exhibits four distinct phases: Phase I (inspiratory baseline / anatomical dead space), Phase II (expiratory upslope / mixed gas), Phase III (alveolar plateau representing true alveolar gas), and Phase IV (rapid inspiratory downslope), with normal physiological EtCO2 maintained between 35 and 45 mmHg (4.7 to 6.0 kPa).

The characteristic 'shark-fin' waveform—marked by an elongated Phase II upslope and a steep upward-sloping Phase III plateau—is pathognomonic for bronchospasm and expiratory airflow obstruction in asthma and COPD, directly tracking therapeutic response to inhaled bronchodilators.

In cardiopulmonary resuscitation, continuous capnography serves as an objective gauge of chest compression quality (EtCO2 >10–20 mmHg), detects compressor fatigue, provides instantaneous recognition of Return of Spontaneous Circulation (ROSC) via a sudden sustained surge in EtCO2 (>35–40 mmHg), and acts as the non-negotiable gold standard for continuous advanced airway verification.

Last updated: September 2026

  • 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics
  • Principles of Continuous Infrared Capnography vs. Colorimetric Devices (CPCF Appendix A #19 & #25)

Continuous waveform capnography is the non-invasive, continuous measurement and graphical display of the partial pressure of carbon dioxide ( C O 2 CO_2 C O 2 ​ ) in exhaled breath, governed under CPCF Area H2.6 and Appendix A #19 & #25. In prehospital medicine, capnography provides an immediate, continuous window into three interconnected physiological pillars: ventilation (rate and tidal volume), perfusion (cardiac output and pulmonary blood flow), and metabolism ( C O 2 CO_2 C O 2 ​ cellular production). THE THREE PHYSIOLOGICAL PILLARS OF CAPNOGRAPHY

  • [METABOLISM] [PERFUSION] [VENTILATION]
  • Cellular production of CO2 --> Transport via venous blood --> Exhalation via lungs
  • (Driven by metabolic rate) to pulmonary capillaries (Driven by RR & Tidal Volume)
  • Infrared Absorption Spectrophotometry Mechanics

Modern multiparameter monitors measure carbon dioxide concentrations utilizing non-dispersive infrared (NDIR) spectrophotometry . Heteratomic gas molecules containing distinct elements, such as C O 2 CO_2 C O 2 ​ , absorb infrared radiation at a highly specific optical absorption band centered at 4.26 micrometers (µm) . As expired gas flows past an infrared emitter, the amount of infrared light absorbed is directly proportional to the number of C O 2 CO_2 C O 2 ​ molecules present, adhering to the Beer-Lambert law. The device calculates the partial pressure of End-Tidal Carbon Dioxide ( EtCO2 ), displayed in millimeters of mercury (mmHg) or kilopascals (kPa) across Canada ( 1 kPa ≈ 7.5 mmHg 1 \text{ kPa} \approx 7.5 \text{ mmHg} 1 kPa ≈ 7.5 mmHg ).

Mainstream vs. Sidestream Sampling Technology

Mainstream Capnometry: The infrared sensor cell is positioned directly inline between the endotracheal tube (ETT) or supraglottic airway (SGA) adapter and the breathing circuit. Provides instantaneous real-time response with zero gas transit delay. Disadvantages: adds physical weight and dead space to the airway circuit, risking accidental extubation; cannot be utilized on non-intubated, spontaneously breathing patients; and the heated sensor probe risks thermal skin injury.

Sidestream Capnometry: Gas is continuously aspirated from the airway through small-bore microbore tubing (at 50–150 mL/min) to an internal optical chamber inside the monitor. Allows monitoring in both intubated patients and spontaneously breathing non-intubated patients via specialized dual-port nasal/oral cannula prongs that simultaneously deliver oxygen while sampling exhaled C O 2 CO_2 C O 2 ​ . Disadvantages: minor transit delay (1–2 seconds) and susceptibility to moisture/secretion clogging in long transports.

Infrared Waveforms vs. Qualitative Colorimetric Detectors

Colorimetric C O 2 CO_2 C O 2 ​ detectors are passive disposable devices containing litmus paper impregnated with cresol red or bromothymol blue. When exposed to expired carbonic acid, the paper changes color reversibly: Purple ( < 0.5 % C O 2 ) ⟶ Tan ( 0.5 − 2 % C O 2 ) ⟶ Yellow ( > 2 % C O 2 ) \text{Purple } (<0.5\% \; CO_2) \longrightarrow \text{Tan } (0.5 - 2\% \; CO_2) \longrightarrow \text{Yellow } (>2\% \; CO_2) Purple ( < 0.5% C O 2 ​ ) ⟶ Tan ( 0.5 − 2% C O 2 ​ ) ⟶ Yellow ( > 2% C O 2 ​ )

While popularized by the memory mnemonic "Purple is Poor, Yellow is Good," colorimetric devices have severe clinical limitations:

Qualitative Only: Provides no numerical measurement (cannot diagnose hypo- or hyperventilation).

No Waveform Morphology: Completely incapable of detecting bronchospasm, air trapping, or respiratory fatigue.

False Negatives in Low-Flow States: During cardiac arrest with low cardiac output, exhaled C O 2 CO_2 C O 2 ​ may be insufficient to turn the litmus paper yellow, leading rescuers to mistakenly pull out a properly placed endotracheal tube.

False Positives: Exposure to acidic gastric secretions or carbonated beverages swallowed into the esophagus can turn the paper yellow in the absence of tracheal ventilation.

Canadian Practice Standard: Continuous infrared waveform capnography is the mandatory, non-negotiable gold standard for confirming and continuously monitoring all advanced airways (ETT and supraglottic devices). Qualitative colorimetric devices are acceptable only as a temporary backup when capnography hardware fails.

Normal Capnogram Morphology & Physiological Phases

A normal capnogram exhibits a crisp rectangular or square-wave profile consisting of four distinct physiological phases: NORMAL WAVEFORM CAPNOGRAM (RECTANGULAR PROFILE)

  • EtCO2
  • (mmHg) Phase III: Alveolar Plateau [Peak = EtCO2 (35–45 mmHg)]
  • 40 | ------------------------+

| / | Phase IV / Phase 0:

  • | / | Inspiratory Downslope
  • | / Phase II: |
  • | / Expiratory Upslope |
  • 0 +----------+ +-----------------
  • Phase I: Baseline (Dead Space) Next Inhalation
  • The Four Phases of Normal Exhalation

Phase I (Inspiratory / Dead Space Baseline): Represents the very beginning of exhalation. The gas clearing the sensor originated in the anatomical dead space (trachea, pharynx, major bronchi), which did not participate in alveolar capillary gas exchange and contains zero carbon dioxide. The baseline must remain flat at 0 mmHg .

Phase II (Early Expiratory Upslope): Represents the rapid transition as gas from the conducting dead space mixes with carbon dioxide-rich gas arriving from the alveoli. Characterized by a steep, near-vertical ascending slope.

Phase III (Alveolar Plateau): Represents the continuous exhalation of pure alveolar gas from across all pulmonary segments. Characterized by a horizontal or gently upward-sloping plateau. The absolute peak of Phase III at the very end of exhalation is sampled by the monitor as the End-Tidal CO2 (EtCO2) value.

Phase IV / Phase 0 (Inspiratory Downslope): The patient begins the next inhalation of ambient air or oxygen. Fresh, C O 2 CO_2 C O 2 ​ -free gas rushes past the sensor, causing an instantaneous, vertical plunge back down to the baseline of 0 mmHg .

Physiological Norms & Ventilation Dynamics

Normal Arterial Partial Pressure of CO2 ( P a C O 2 PaCO_2 P a C O 2 ​ ): 35 to 45 mmHg (4.7 to 6.0 kPa).

Normal End-Tidal CO2 (EtCO2): 35 to 45 mmHg (4.7 to 6.0 kPa) .

Normal Alveolar-to-Arterial Gradient: In healthy individuals with matched ventilation and perfusion ( V / Q = 1 V/Q = 1 V / Q = 1 ), EtCO2 is typically 2 to 5 mmHg lower than arterial P a C O 2 PaCO_2 P a C O 2 ​ due to normal physiological dead space dilution. In states of shock, pulmonary embolism, or severe ventilation-perfusion mismatch, this gradient widens dramatically.

Pathological Waveforms & Clinical Respiratory Dynamics

Careful inspection of waveform morphology allows paramedics to diagnose acute pulmonary pathologies and track clinical response to therapy in real time. PATHOLOGICAL WAVEFORM PATTERNS

  • [SHARK-FIN WAVEFORM] --> Bronchospasm & Airflow Obstruction (Asthma / COPD)
  • Sloping Phase II & Steep Ascending Phase III (No flat plateau)
  • Resolves toward square-wave box following inhaled Salbutamol / Ipratropium
  • [CURARE CLEFT] --> Diaphragmatic Muscle Recovery Fighting Ventilator
  • Distinct downward dip appearing in the final third of Phase III plateau
  • [ELEVATED BASELINE (>0 mmHg)]--> Rebreathing Carbon Dioxide
  • Exhausted CO2 soda-lime absorbent, sticky BVM exhalation valve, or inadequate flow
  • [HYPOVENTILATION] --> Rectangular Box with EtCO2 >45 mmHg (Opioid tox, CNS depression)
  • [HYPERVENTILATION] --> Rectangular Box with EtCO2 <35 mmHg (Anxiety, over-bagging, pain)
  • Obstructive Airway Disease: The Pathognomonic "Shark-Fin"

In acute bronchospasm (severe asthma, COPD exacerbation, or respiratory anaphylaxis), widespread bronchiolar constriction and mucosal edema create marked airway resistance. Alveoli empty at uneven, turbulent rates throughout expiration:

Phase II Elongation: The expiratory upslope loses its steep verticality and slants diagonally to the right.

Phase III Loss of Plateau: The alveolar plateau never achieves a flat line; instead, it slopes continuously upward as poorly ventilated, high-resistance alveoli slowly release their trapped C O 2 CO_2 C O 2 ​ at the very end of exhalation.

Visual Profile: The resulting tracing perfectly resembles the dorsal fin of a shark ( "Shark-Fin Pattern" ).

Clinical Tracking: The shark-fin contour directly correlates with the severity of bronchospasm. As bronchodilator therapy (inhaled beta-2 agonists like salbutamol, anticholinergics like ipratropium, and systemic corticosteroids) relieves smooth muscle constriction, the waveform widens and progressively normalizes back into a crisp rectangular box.

Systemic Ventilatory Derangements

Hypoventilation / Hypercapnia ( E t C O 2 > 45 mmHg EtCO_2 > 45 \text{ mmHg} EtC O 2 ​ > 45 mmHg ): Tall rectangular waveforms with elevated alveolar plateaus (frequently 50–75+ mmHg). Caused by depressed respiratory rate or tidal volume from central nervous system depression (opioid overdose, head trauma), neuromuscular disease, or hypoventilation during mechanical ventilation. Titrate assisted positive-pressure ventilations to normalize EtCO2 between 35 and 45 mmHg.

Hyperventilation / Hypocapnia ( E t C O 2 < 35 mmHg EtCO_2 < 35 \text{ mmHg} EtC O 2 ​ < 35 mmHg ): Short rectangular waveforms with depressed alveolar plateaus (frequently 15–30 mmHg). Caused by psychogenic hyperventilation, pain, metabolic acidosis compensation, or iatrogenic rescuer over-ventilation with a bag-valve-mask (BVM).

Continuous Capnography in Cardiopulmonary Resuscitation (CPR)

During cardiac arrest, continuous capnography is the ultimate physiological monitor. Because cellular C O 2 CO_2 C O 2 ​ production and rescuer-delivered minute ventilation are relatively fixed during resuscitation, EtCO2 correlates directly with pulmonary blood flow, serving as an instantaneous surrogate for cardiac output produced by chest compressions .

Resuscitation Parameter Capnographic Manifestation Physiological Mechanism & Paramedic Action

High-Quality Chest Compressions EtCO2 10–20+ mmHg (typically 15–25 mmHg) Adequate chest compression depth (5–6 cm) and rate (100–120/min) generate approximately 25–35% of normal cardiac output, carrying systemic C O 2 CO_2 C O 2 ​ to the lungs.

Inadequate Compressions / Rescuer Fatigue EtCO2 <10 mmHg or steady downward decay Provider fatigue causes compression depth to decay without rescuer awareness. EtCO2 dropping below 10 mmHg indicates failing perfusion; immediately swap compressors before the 2-minute cycle ends.

Return of Spontaneous Circulation (ROSC) Sudden, sustained surge in EtCO2 to >35–40 mmHg (often leaping by 15–25 mmHg in one cycle) Restoration of spontaneous heartbeat causes an explosive wash-out of accumulated tissue metabolic C O 2 CO_2 C O 2 ​ into pulmonary circulation. Withhold compressions and immediately assess pulse and rhythm.

Futility / Termination of Resuscitation EtCO2 persistently <10 mmHg after 20 minutes Indicates profound metabolic cellular death, failure of coronary perfusion, and irreversible arrest. Serves as a primary objective criterion during medical consultation for termination of resuscitation (TOR). CAPNOGRAPHIC SURGE UPON RETURN OF SPONTANEOUS CIRCULATION (ROSC)

  • EtCO2
  • (mmHg)
  • 45 | +-----------------
  • 40 | / SUDDEN SURGE
  • 35 | / (ROSC Achieved: >35-40 mmHg)

30 | / Immediate pulse check!

  • 20 | CPR Compressions /
  • 15 | +--+ +--+ +--+ +--+ +--+ /
  • 10 | | | | | | | | | | | /
  • 0 +----+--+---+--+---+--+---+--+---+--+---+------------------------
  • Advanced Airway Verification & Shock/Metabolic Surveillance
  • Advanced Airway Verification & Instant Dislodgement Detection

Accidental unrecognized esophageal intubation or tube displacement during patient movement is a catastrophic, fatal complication in emergency medicine. Physical assessment alone (auscultation of breath sounds, visualization of chest rise, epigastric auscultation, and tube condensation) has repeatedly proven fallible in noisy, moving prehospital environments.

Continuous waveform capnography is the mandatory gold standard for confirming and continuously verifying endotracheal tubes and supraglottic airways (e.g., i-gel, King LT):

Tracheal Confirmation: Continuous display of consistent, rectangular waveforms over at least 5 consecutive breaths confirms placement within the respiratory tract.

Esophageal Intubation Detection: When an ETT is placed in the esophagus, small amounts of swallowed atmospheric C O 2 CO_2 C O 2 ​ or carbonated beverages may produce 1 or 2 small, decaying waveforms that immediately flatline to 0 mmHg . A flatline capnogram confirms esophageal placement until proven otherwise; immediately extubate and re-oxygenate.

Instant Dislodgement Alert: Transferring patients from floors to stretchers, maneuvering down narrow stairwells, or driving over bumpy roads frequently dislodges advanced airways. Waveform capnography provides instantaneous visual and audible notification if the tube becomes dislodged, allowing immediate correction before hypoxic cardiac arrest ensues.

Capnography in Metabolic Acidosis, Shock & Sepsis

In non-intubated, spontaneously breathing patients, continuous capnography via dual-port nasal cannula is an invaluable diagnostic tool for metabolic surveillance:

Metabolic Acidosis & Kussmaul Respiration: In diabetic ketoacidosis (DKA), lactic acidosis, and toxic ingestions (salicylates, ethylene glycol), excess hydrogen ions ( H + H^+ H + ) stimulate peripheral and central chemoreceptors. The brain drives compensatory hyperventilation (rapid, deep Kussmaul breathing) to blow off carbon dioxide, driving P a C O 2 PaCO_2 P a C O 2 ​ and EtCO2 down in an attempt to restore normal physiological pH. In suspected DKA, an E t C O 2 < 29 mmHg EtCO_2 < 29 \text{ mmHg} EtC O 2 ​ < 29 mmHg strongly correlates with significant acidosis, and an E t C O 2 < 19 mmHg EtCO_2 < 19 \text{ mmHg} EtC O 2 ​ < 19 mmHg indicates severe, life-threatening ketoacidosis.

Septic & Hypovolemic Shock: Cellular hypoperfusion impairs aerobic metabolism and drops cardiac output. Decreased venous return to the lungs produces low pulmonary capillary blood flow, widening the alveolar-arterial gradient and sharply depressing EtCO2. In emergency patients with suspected sepsis, an E t C O 2 ≤ 25 mmHg EtCO_2 \le 25 \text{ mmHg} EtC O 2 ​ ≤ 25 mmHg strongly correlates with elevated serum lactate levels ( > 4.0 mmol/L >4.0 \text{ mmol/L} > 4.0 mmol/L ) and independently predicts elevated in-hospital mortality, serving as a rapid prehospital trigger for sepsis protocol activation and fluid resuscitation.

  • Clinical Scenario: Cardiac Arrest Resuscitation with ROSC Recognition
  • Prehospital Vignette: Out-of-Hospital Cardiac Arrest

Paramedics respond to a 58-year-old male found unresponsive and pulseless on a commercial office floor. Rescuers initiate CPR while the monitor shows coarse ventricular fibrillation. Defibrillation is delivered at 200 joules biphasic, and chest compressions are immediately resumed.

Advanced Airway & Capnography Deployment:

During CPR, the crew inserts an i-gel supraglottic airway without interrupting chest compressions and connects inline continuous sidestream waveform capnography.

Initial CPR Waveform: Displays regular rectangular waveforms with an EtCO2 of 18 mmHg , confirming high-quality chest compressions and proper airway seating.

Trending Rescuer Fatigue & Compression Optimization:

At minute 6 of resuscitation, the paramedic observing the monitor notices the EtCO2 tracing steadily deteriorating from 18 mmHg down to 8 mmHg . The compressor is not aware that their compression depth has decayed.

The team leader orders an immediate compressor rotation. The new compressor establishes deep, rapid compressions, and the EtCO2 instantly rebounds to 20 mmHg .

Instantaneous ROSC Identification:

At minute 10, immediately following a second defibrillation shock and epinephrine administration, the EtCO2 waveform suddenly surges from 16 mmHg to 44 mmHg over two cardiac cycles.

Recognizing this capnographic surge as the earliest indicator of Return of Spontaneous Circulation (ROSC) , the team leader halts compressions. A strong, bounding carotid pulse is palpated at a rate of 88 bpm.

The patient is maintained on continuous capnography (titrating ventilations to an EtCO2 of 35–40 mmHg to prevent cerebral vasoconstriction from hyperventilation) while a post-resuscitation 12-lead ECG is obtained, revealing an anterior STEMI that triggers immediate prehospital PCI bypass activation.